Association between visceral adiposity index and heart failure: A cross‐sectional study

Author:

Zhang Xinyu1,Sun Yijun1,Li Ying1,Wang Chengwei1,Wang Yi1,Dong Mei1,Xiao Jie1,Lin Zongwei1,Lu Huixia1ORCID,Ji Xiaoping1ORCID

Affiliation:

1. Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan Shandong China

Abstract

AbstractBackgroundObesity is an important risk factor for heart failure (HF).HypothesisVisceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk for HF has not been studied.MethodsA cross‐sectional study involving 28 764 participants ≥18 years of age from the National Health and Nutrition Examination Survey (NHANES), 2009–2018, in the United States was performed. VAI was calculated using body mass index (BMI), waist circumference (WC), triglycerides (TG), and high‐density lipoprotein cholesterol. VAI was analyzed as a continuous and categorical variable to examine its association with HF. Subgroup analysis was also performed.ResultsThe highest VAI (fourth quartile [Q4]) was found among males, BMI, systolic and diastolic blood pressure, WC, hypertension, diabetes, liver disease, coronary heart disease, smoking, total cholesterol, and TG. More participants in Q4 took β‐receptor blockers, angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers/angiotensin receptor‐neprilysin inhibitor, calcium channel blockers, and antidiabetic and antihyperlipidemic medications. Participants with HF exhibited greater VAI. A per‐unit increase in VAI resulted in a 4% increased risk for HF (odds ratio [OR] 1.04 [95% confidence interval (CI) 1.02–1.05]). After multivariable adjustment, compared with the lowest quartile, the OR for Q3 was 1.55 (95% CI 1.24–1.94). Subgroup analysis revealed no significant interactions between VAI and specific subgroups.ConclusionVAI was independently associated with the risk for HF. As a noninvasive index of visceral adiposity, VAI could be used for a “one shot” assessment of HF risk and may serve as a novel marker.

Funder

National Natural Science Foundation of China

China International Medical Foundation

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference39 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Chinese guidelines for the diagnosis and treatment of heart failure 2018;Heart Failure Group of Chinese Society of Cardiology of Chinese Medical A, Chinese Heart Failure Association of Chinese Medical Doctor A, Editorial Board of Chinese Journal of C;Zhonghua Xin Xue Guan Bing Za Zhi,2018

3. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

4. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

5. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3